Assessing Cardiovascular Risk to Guide Diagnosis and Treatment of Hypertension
This study uses NHANES data to assess the representativeness of the findings of SPRINT and the HOPE-3 trial to US patients and to explore the cardiovascular disease risk profiles of various populations with elevated systolic blood pressure.